L-Dex® Analysis for Lymphedema - Medical / Health Care - Medical Equipment

Offer your patients peace of mind. Know their L-Dex score with the leading technology for point-of-care lymphedema assessment.

Most popular related searches

Designed for Lymphedema

The L-Dex score, only available from ImpediMed, is designed to detect small lymphedema-related fluid changes in the limbs.
L-Dex compares the fluid in a limb at-risk for lymphedema to a healthy limb in order to help detect lymphedema.
L-Dex is FDA-cleared for: unilateral lymphedema and bilateral lymphedema, arms and legs, and women and men.

Accurate Detection

L-Dex is validated to detect lymphedema at its earliest, subclinical stage
Detects fluid changes as small as 36 ml (2.4 tablespoons)
Validated against lymphoscintigraphy
80% Sensitive and 90% Specific in detecting subclinical lymphedema following cancer surgery with a 6.5 change from a pre-treatment baseline

Demonstrated Outcomes

81% lower incidence of chronic cancer-related lymphedema with BIS L-Dex monitoring and intervention than with circumference monitoring in a meta-analysis of 67,000 patients
Statistically lower rates of chronic lymphedema in high-risk patients and short-term and long-term follow-up
Consistent reduction in lymphedema progression, study after study

Extensive Experience

16 of the 31 members of the National Comprehensive Cancer Network^® (NCCN^®) use SOZO with L-Dex
BIS is recommended in lymphedema clinical practice guidelines from the American Physical Therapy Association, eviCore Healthcare, and the National Lymphedema Network
Major institutions including University of Kansas, University of Pittsburgh Medical Center, Memorial Sloan Kettering, and MD Anderson have published their experience using L-Dex

Stay in the loop!